Multicenter Preliminary Experience Utilizing Boceprevir with Pegylated Interferon and Ribavirin for Treatment of Recurrent Hepatitis C Genotype 1 after Liver Transplantation

被引：0
|
作者：
Aqel, Bashar [1 ,2 ]
Koning, Ludi [3 ]
Charlton, Michael [3 ]
Carey, Elizabeth J. [1 ,2 ]
Byrne, Thomas J. [1 ,2 ]
Rakela, Jorge [1 ,2 ]
Vargas, Hugo E. [1 ,2 ]
机构：
[1] Mayo Clin, Div Gastroenterol, Phoenix, AZ USA
[2] Mayo Clin, Div Hepatol, Phoenix, AZ USA
[3] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
706
引用
收藏
页码：530A / 530A
页数：1
相关论文
共 50 条
  • [1] Preliminary Experience Utilizing Boceprevir with Pegylated Interferon and Ribavirin for Treatment of Recurrent Hepatitis C Genotype 1 after Liver Transplantation
    Aqel, B.
    Carey, E.
    Douglas, D.
    Byrne, T.
    Rakela, J.
    Susan, W.
    Vargas, H.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 144 - 144
  • [2] Multicenter Experience Using Telaprevir or Boceprevir With Peginterferon and Ribavirin to Treat Hepatitis C Genotype 1 After Liver Transplantation
    Pungpapong, Surakit
    Aqel, Bashar A.
    Koning, Ludi
    Murphy, Jennifer L.
    Henry, Tanisha M.
    Ryland, Kristen L.
    Yataco, Maria L.
    Satyanarayana, Raj
    Rosser, Barry G.
    Vargas, Hugo E.
    Charlton, Michael R.
    Keaveny, Andrew P.
    [J]. LIVER TRANSPLANTATION, 2013, 19 (07) : 690 - 700
  • [3] Treatment of patients with recurrent hepatitis C after liver transplantation with pegylated interferon and ribavirin.
    Samuel, D
    [J]. HEPATOLOGY, 2003, 38 (04) : 531A - 531A
  • [4] Pegylated-interferon and ribavirin for recurrent hepatitis C after liver transplantation - A preliminary analysis.
    Mukherjee, S
    Gilroy, RK
    McCashland, TM
    Schafer, DF
    Zetterman, RK
    Sorrell, MF
    [J]. HEPATOLOGY, 2002, 36 (04) : 184A - 184A
  • [5] Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantation
    Dinges, S.
    Morard, I.
    Heim, M.
    Dufour, J.-F.
    Mullhaupt, B.
    Giostra, E.
    Clavien, P. -A.
    Mentha, G.
    Negro, F.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2009, 11 (01) : 33 - 39
  • [6] Initial Experience Utilizing Telaprevir with Peginterferon and Ribavirin for Treatment of Hepatitis C Genotype 1 after Liver Transplantation
    Pungpapong, S.
    Murphy, J.
    Henry, T.
    Satyanarayana, R.
    Rosser, B.
    Yataco, M.
    Harnois, D.
    Patel, T.
    Keaveny, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 430 - 430
  • [7] Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation
    Cicinnati, V. R.
    Iacob, S.
    Klein, C. G.
    Baba, H. A.
    Sotiropoulos, G. C.
    Hilgard, P.
    Erim, Y.
    Broelsch, C. E.
    Gerken, G.
    Beckebaum, S.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (02) : 291 - 303
  • [8] Pegylated interferon ALFA-2A and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    Rogge, DV
    Weaver, L
    Schafer, DF
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S101 - S101
  • [9] Pegylated interferon alfa-2a and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (10) : 4403 - 4405
  • [10] Interferon-α and ribavirin for the treatment of recurrent hepatitis C after liver transplantation
    de Vera, ME
    Smallwood, GA
    Rosado, K
    Davis, L
    Martinez, E
    Sharma, S
    Stieber, AC
    Heffron, TG
    [J]. TRANSPLANTATION, 2001, 71 (05) : 678 - 686
12345